$multiB AUM APAC based L/S equities Hedge Fund - APAC Healthcare Analyst and Greater China specialist

Bilingual investment professional with a core focus on the China Healthcare Sector

Established in late 2000s, our client is a multi$B AUM HK based Fund. The firm takes a long-term industrialist mindset in investing in companies that have superior business models, favorable growth prospects and the potential to take advantage of long-term positive structural dynamics of Asia countries and economies.

As a genuine thought partner with its investee companies, the fund assists in increasing long-term corporate value and build strong and meaningful long-term relationships with investee companies.

-          Pan Asia Fundamental L/S equities
-          Strong performance track record and had positive returns since inception. HQ in HK
-          Approx 10 investment professionals covering all sectors globally
-          Very fundamentally driven, and tend to hold positions for relatively long periods – 1-3years

- Experienced in a strategic consulting firm, HC IBD/PE/VC fund, or buy/sell side analyst experience with a focus on China Healthcare Sector (strong familiarity with Biomedical or biopharma areas)
- Fluent in English and Mandarin
- Top tier academics and experience in top tier firm (ideally had some previous experience living/working out of Asia).
- Advanced Medical, Pharmaceutical, or related background is a strong preference OR prior specialisation as a China Healthcare/Biomedical analyst on buy/sell side
- Has a strong genuine passion and interest for the China Healthcare space and global Healthcare market.